Cite
MLA Citation
M.C. Genovese et al.. “FRI0228 Sarilumab Dose Reduction To Manage Laboratory Abnormalities in An Open-Label Extension Study in RA Patients.” Annals of the rheumatic diseases, vol. 75, n.d., pp. 515–516. http://access.bl.uk/ark:/81055/vdc_100135136460.0x000054